Abstract
Get full access to this article
View all access options for this article.
References
1.
Patel
IH
Levy
RH
Cutler
RE
. Phenobarbital-valproic acid interaction . Clin Pharmacol Ther
1980 ; 27 : 515 –21 .
2.
DiAugustine
RP
Fouts
JR
. The effects of unsaturated fatty acids on hepatic microsomal drug metabolism and cytochrome P-450 . Biochem J
1969 ; 115 : 547 –54 .
3.
Lang
M
. Depression of drug metabolism in liver microsomes after treating rats with unsaturated fatty acids . Gen Pharmacol
1976 ; 7 : 415 –9 .
4.
Kapetanovic
IM
Kupferberg
HJ
Porter
RJ
Theodore
W
Schulman
E
Penry
JK
. Mechanism of valproate-phenobarbital interaction in epileptic patients . Clin Pharmacol Ther
1981 ; 29 : 480 –6 .
5.
Loiseau
P
Brachet
A
Henry
P
. Concentration of dipropylacetate in plasma . Epilepsia
1975 ; 16 : 609 –15 .
6.
Barnes
SE
Bower
BD
. Sodium valproate in the treatment of intractable childhood epilepsy . Dev Med Child Neurol
1975 ; 17 : 175 –81 .
7.
Schobben
F
van der Kleijn
E
Gabreals
FJM
. Pharmacokinetics of di-n-propylacetate in epileptic patients . Eur J Clin Pharmacol
1975 ; 8 : 97 –105 .
8.
Meinardi
H
Hanke
NJF
VanBeveren
J
. Sodium di-n-propylacetate: Estimation of effective serum levels . Pharm Weekbl
1974 ; 109 : 45 –7 .
9.
Meijer
JWA
Hessing-Brand
L
. Determination of lower fatty acids, particularly the antiepileptic dipropylacetic acid in biological materials, by means of micro diffusion and gas chromatography . Clin Chim Acta
1973 ; 43 : 215 –22 .
10.
Schobben
F
van der Kleijn
E
. Determination of sodium di-n-propylacetate in plasma gas liquid chromatography . Pharm Weekbl
1974 ; 109 : 30 –3 .
11.
Richens
A
Ahmad
S
. Controlled trial of sodium valproate in severe epilepsy . Br Med J
1975 ; 4 : 255 –6 .
12.
Wilder
BJ
Willmore
LJ
Bruni
J
Villarreal
HJ
. Valproic acid: Interaction with other anticonvulsant drugs . Neurology
1978 ; 28 : 892 –6 .
13.
Richens
A
. Clinical pharmacokinetics of phenytoin . Clin Pharmacokinet
1979 ; 4 : 153 –69 .
14.
Gugler
R
von Unruch
GE
. Clinical pharmacokinetics of valproic acid . Clin Pharmacokinet
1980 ; 5 : 67 –83 .
15.
Monks
A
Boobis
S
Wadsworth
J
Richens
A
. Plasma protein binding interaction between phenytoin and valproic acid in vitro . Br J Clin Pharmacol
1978 ; 6 : 487 –92 .
16.
Dahlqvist
R
Borga
O
Rane
A
Walsh
Z
Sjoqvuist
F
. Decreased plasma protein binding of phenytoin in patients on valproic acid . Br J Clin Pharmacol
1979 ; 8 : 547 –52 .
17.
Mattson
RH
Cramer
JA
Williamson
PD
Novelly
RA
. Valproic acid in epilepsy: Clinical and pharmacological effects . Ann Neurol
1978 ; 3 : 20 –5 .
18.
Monks
A
Richens
A
. Effect of single doses of sodium valproate on serum phenytoin levels and protein binding in epileptic patients . Clin Pharmacol Ther
1980 ; 27 : 89 –95 .
19.
Perucca
E
Hebdige
S
Frigo
GM
Gatti
G
Lecchini
S
Crema
A
. Interaction between phenytoin and valproic acid: Plasma protein binding and metabolic effects . Clin Pharmacol Ther
1980 ; 28 : 779 –89 .
20.
Levy
G
Yacobi
A
. Effect of plasma protein binding on elimination of warfarin . J Pharm Sci
1974 ; 63 : 805 –6 .
21.
Bruni
J
Gallo
JM
Lee
CS
Perchalski
RJ
Wilder
BJ
. Interactions of valproic acid with phenytoin . Neurology
1980 ; 30 : 1233 –6 .